Jardiance® (empagliflozin)
for Heart Failure

Jardiance (empagliflozin) is an SGLT-2 inhibitor that manages type 2 diabetes, heart failure, and chronic kidney disease (CKD). It lowers blood sugar by increasing glucose excretion in urine, reduces cardiovascular risks, and slows CKD progression by improving kidney function and reducing hospitalizations. Its heart benefits may result from optimizing heart muscle metabolism and diastolic function.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Heart Failure - HF